Literature DB >> 2216225

In vitro fertilization in unstimulated cycles: a clinical trial using hCG for timing of follicle aspiration.

R J Paulson1, M V Sauer, M M Francis, T M Macaso, R A Lobo.   

Abstract

In vitro fertilization (IVF) was performed in normally ovulatory women after the follicular phase of an unstimulated cycle. Twenty patients initiated 36 cycles of unstimulated IVF, with serial ultrasound examinations and hCG 10,000 IU given when the follicle was mature. Thirty aspirations were carried out under intravenous sedation with transvaginal ultrasound guidance. One or more oocytes were obtained in 29 aspirations (97%) for a total of 52 oocytes (average 1.7); 37 fertilized (71%), two were polyspermic, and 35 cleaved (67%). Seventeen aspirations (57%) yielded multiple oocytes. All 25 oocytes obtained from dominant follicles fertilized (100%), and 12 of 27 oocytes from secondary follicles fertilized (44%) (P less than .05 versus dominant follicles), with one polyspermic fertilization in each group. Sixteen cycles resulted in a single embryo transfer (ET), eight had two embryos, and one had three embryos transferred (36% multiple ET). Five clinical pregnancies (20% per ET, 17% per retrieval) resulted in four ongoing pregnancies (16% per ET, 13% per retrieval), all singletons. Our results suggest that in selected cases, IVF in unstimulated cycles may be a clinically viable alternative to stimulated cycles, with preliminary success rates in the range of national averages for stimulated cycles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216225     DOI: 10.1097/00006250-199011000-00012

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  Periovulatory serum inhibin-a in women with a diminished ovarian reserve.

Authors:  S R Lindheim; M A Cohen; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

2.  Case report: treatment of congenital vas obstruction with sperm aspiration, nonstimulated in vitro fertilization, and nonsurgical tubal embryo transfer.

Authors:  A Steinleitner; I Sharlip; H Lambert; M Garcia; R Nachtigall
Journal:  J Assist Reprod Genet       Date:  1992-08       Impact factor: 3.412

3.  Results of intracytoplasmic sperm injection of single oocyte in 362 unstimulated cycles.

Authors:  Veljko Vlaisavljević; Borut Kovacic; Milan Reljic; Vida Gavrić Lovrec; Mojca Cizek Sajko
Journal:  J Assist Reprod Genet       Date:  2002-03       Impact factor: 3.412

4.  The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.

Authors:  S R Lindheim; P L Chang; A Vidali; M Ferin; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

5.  The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.

Authors:  S R Lindheim; M V Sauer; M M Francis; T M Macaso; R A Lobo; R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-01       Impact factor: 3.412

6.  The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome.

Authors:  M J Levy; D B Smotrich; E A Widra; A W Sagoskin; D L Murray; J L Hall
Journal:  J Assist Reprod Genet       Date:  1995-03       Impact factor: 3.412

7.  Influence of follicular phase duration on human granulosa-luteal cell subpopulations in natural and stimulated IVF-ET cycles.

Authors:  K Gersak; T Tomazevic
Journal:  J Assist Reprod Genet       Date:  1995-10       Impact factor: 3.412

8.  Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience.

Authors:  R J Paulson; M V Sauer; R A Lobo
Journal:  J Assist Reprod Genet       Date:  1994-01       Impact factor: 3.412

9.  Minimal stimulation with simplified monitoring for in vitro fertilization.

Authors:  J B Massey; P E Ingargiola; M J Tucker; D E Mitchell-Leef; G Wright
Journal:  J Assist Reprod Genet       Date:  1994-08       Impact factor: 3.412

10.  Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: evidence for a second flare.

Authors:  J L Deaton; P Bauguess; C S Huffman; K A Miller
Journal:  J Assist Reprod Genet       Date:  1996-05       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.